United States · FDA National Drug Code directory

Respiforce A-HP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43857-0612_f869579c-5b5b-4a5c-b98c-db6b1281a585
Product NDC
43857-0612
Form
LIQUID
Composition / generic term
Arsenicum Album, Belladonna, Ipecacuanha, Kali Carbonicum, Lobelia Inflata, Natrum Sulphuricum, Silicea
Labeler
BioActive Nutritional, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20210903
Source listing expiry
20271231

Source-listed ingredients

  • ARSENIC TRIOXIDE — 30 [hp_X]/mL
  • ATROPA BELLADONNA — 30 [hp_X]/mL
  • IPECAC — 30 [hp_X]/mL
  • POTASSIUM CARBONATE — 30 [hp_X]/mL
  • LOBELIA INFLATA WHOLE — 30 [hp_X]/mL
  • SODIUM SULFATE — 30 [hp_X]/mL
  • SILICON DIOXIDE — 30 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43857-0612-1) · 43857-0612-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →